This was an analysis of about 175,000 records of people with diabetes who used semaglutide - compared with an equal number of people with diabetes who were taking other drugs unlike GLP-1 drugs
4 mg per week for 4 weeks, then 8 mg weekly for the rest of the study 6
cross-trial comparisons should be interpreted with caution
The future question will not be: Which treatment produces the largest number on the scale? It will be: Which treatment produces the greatest improvement in health while preserving strength, function, and long-term physical reserve? The bottom line Lean mass matters
State-Specific Requirements Some States May Require: Video consultation (not just messaging) More extensive documentation Lab work before prescribing Additional consent forms Specific waiting periods Legitimate providers handle state-specific requirements automatically
Tonneijck L, Smits MM, Muskiet MHA, et al